Skip to main content
Veterinary Medicines

Api-Bioxal 632.7 mg/g bee-hive powder

Authorised
  • Oxalic acid dihydrate

Product identification

Medicine name:
Api-Bioxal 632.7 mg/g bee-hive powder
Api-Bioxal, 632,7 mg/g, prašak za primjenu u košnici
Active substance:
  • Oxalic acid dihydrate
Target species:
  • Honey bee
Route of administration:
  • In-hive use

Product details

Active substance and strength:
  • Oxalic acid dihydrate
    886.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Bee-hive powder
Withdrawal period by route of administration:
  • In-hive use
    • Honey bee
      • Honey
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AG03
Authorisation status:
  • Valid
Authorised in:
  • Croatia
Available in:
  • Croatia
Package description:
  • Multilayer polyester-Aluminium-Polyethylene laminated bags, heat sealed, containing 350 g of powder.
  • Multilayer polyester-Aluminium-Polyethylene laminated bags, heat sealed, containing 175 g of powder.
  • Multilayer polyester-Aluminium-Polyethylene laminated bags, heat sealed, containing 35 g of powder.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Chemicals Laif S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chemifarma S.p.A.
Responsible authority:
  • Ministry Of Agriculture Veterinary And Food Safety Directorate
Authorisation number:
  • UP/I-322-05/21-01/268
Date of authorisation status change:
Reference member state:
  • Italy
Procedure number:
  • IT/V/0132/001
Concerned member states:
  • Austria
  • Bulgaria
  • Croatia
  • France
  • Ireland
  • Norway
  • Portugal
  • Romania
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 11/11/2024
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Croatian (PDF)
Published on: 27/03/2025
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."